Sidra Medicine in Qatar has advanced its approach to pediatric obesity care by implementing comprehensive, multidisciplinary treatment programs tailored to address the growing prevalence of obesity among children and adolescents in the country. Utilizing state-of-the-art diagnostic tools and innovative therapeutic strategies, the medical center aims to provide specialized care that responds to the complex nature of childhood obesity as a chronic medical condition.
Qatar has seen rising rates of childhood obesity attributed to rapid economic growth, urbanization, dietary changes, and decreased physical activity. Data indicate that obesity affects a considerable portion of the younger population: among children aged 5 to 10 years, the prevalence stands at 17.9%, while adolescents aged 11 to 18 years show a rate of 27.5%. Notably, obesity affects 40% of Qatari adolescent boys within this age group. The World Health Organization reported that in 2022, obesity among children and adolescents aged 5 to 19 in Qatar was estimated at 23.9%, underscoring the scale of the challenge.
Sidra Medicine’s comprehensive model recognizes that childhood obesity often involves intertwined medical, psychological, behavioral, and social factors. Its children and young people’s services encompass specialties such as endocrinology, adolescent medicine, mental health, nutrition, and general pediatrics. Treatment plans are individualized, taking into account each child’s medical history, growth trajectory, lifestyle, and family environment. The multidisciplinary care team includes pediatricians, endocrinologists, dietitians, psychologists, nurses, and exercise specialists, all collaborating to support improvements in metabolic health, physical fitness, emotional wellbeing, and overall quality of life.
This integrated approach reflects modern medical understanding that childhood obesity increases the risk of serious health complications later in life, including type 2 diabetes, hypertension, cardiovascular disease, sleep disorders, and psychological difficulties.
Beyond addressing common obesity cases, Sidra Medicine also specializes in diagnosing and managing rare and complex forms of childhood obesity. In 2026, the institution reported a notable medical advancement involving the treatment of acquired hypothalamic obesity in a young patient—a condition arising from neurological injury. This case, documented in the journal Frontiers in Endocrinology, illustrated how precision medicine and targeted endocrine therapies can improve outcomes for children facing severe, atypical obesity.
Further expanding its specialized services, Sidra Medicine established Qatar’s first comprehensive adolescent eating disorders clinic in 2025. The program caters to young people aged 8 to 17 and integrates care from pediatricians, psychologists, dietitians, and social workers to provide holistic support for this vulnerable population.
Through these initiatives, Sidra Medicine continues to position itself as a leader in pediatric healthcare in Qatar, addressing the multifaceted challenges of childhood obesity with advanced, coordinated care.